GUANGZHOU CELLPROTEK PHARMACEUTICAL CO LTD has a total of 67 patent applications. It increased the IP activity by 1250.0%. Its first patent ever was published in 2011. It filed its patents most often in Canada, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BARR LAB INC, GUANGZHOU CELLPROTEK PHARMACEUTICAL LTD and CASSIOPEA S P A.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 8 | |
#2 | United States | 8 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | Australia | 6 | |
#5 | Israel | 6 | |
#6 | Taiwan | 6 | |
#7 | WIPO (World Intellectual Property Organization) | 6 | |
#8 | Republic of Korea | 5 | |
#9 | Singapore | 5 | |
#10 | Brazil | 3 | |
#11 | Hungary | 3 | |
#12 | Serbia | 3 | |
#13 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Steroids | |
#4 | Microorganisms | |
#5 | Peptides | |
#6 | Organic chemistry methods | |
#7 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Yan Guangmei | 41 |
#2 | Yin Wei | 35 |
#3 | Zhang Jingxia | 32 |
#4 | Lin Suizhen | 27 |
#5 | Lu Bingzheng | 24 |
#6 | Huang Yijun | 22 |
#7 | Hu Haiyan | 19 |
#8 | Qiu Pengxin | 19 |
#9 | Sheng Longxiang | 14 |
#10 | Chen Jiesi | 14 |
Publication | Filing date | Title |
---|---|---|
US2019262358A1 | Neuro-protective agents and uses thereof | |
TW201932114A | Compound for treating inflammation-mediated optic neuropathy | |
EP3733189A1 | Application of compound in preparation of drug for treatment of haemorrhagic stroke | |
WO2019129182A1 | 2β,3α,5α-TRIHYDROXYL ANDROSTANE-6-KETONE FOR TREATMENT OF INFLAMMATORY REACTIONS | |
WO2019129179A1 | Use of compound in preparation of drug for treating cerebral small vessel disease |